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Kinase suppressors of Ras 1 and 2 (KSR1 and KSR2)
function as molecular scaffolds to potently regulate
the MAP kinases ERK1/2 and affect multiple cell
fates. Here we show that KSR2 interacts with and
modulates the activity of AMPK. KSR2 regulates
AMPK-dependent glucose uptake and fatty acid
oxidation inmouse embryonic fibroblasts and glycol-
ysis in a neuronal cell line. Disruption of KSR2 in vivo
impairs AMPK-regulated processes affecting fatty
acid oxidation and thermogenesis to cause obesity.
Despite their increased adiposity, ksr2/ mice are
hypophagic and hyperactive but expend less energy
than wild-type mice. In addition, hyperinsulinemic-
euglycemic clamp studies reveal that ksr2/ mice
are profoundly insulin resistant. The expression of
genes mediating oxidative phosphorylation is also
downregulated in the adipose tissue of ksr2/
mice. These data demonstrate that ksr2/ mice
are highly efficient in conserving energy, revealing a
novel role for KSR2 in AMPK-mediated regulation
of energy metabolism.
INTRODUCTION
Molecular scaffolds, which coordinate the interaction of signaling
molecules to affect efficient signal transduction (Burack and
Shaw, 2000; Morrison and Davis, 2003), have the potential to
serve as organizing nodes for multiple biological inputs. Kinase
suppressor of Ras 1 (KSR1) (Kortum and Lewis, 2004; Nguyen
et al., 2002) serves as a scaffold for the coordination of signals366 Cell Metabolism 10, 366–378, November 4, 2009 ª2009 Elseviethrough the Raf/MEK/ERK kinase cascade. Manipulation of
KSR1 reveals its role in regulating the transforming potential of
oncogenic Ras, neuronal and adipocyte differentiation, and repli-
cative life span (Kortum et al., 2005, 2006; Kortum and Lewis,
2004; Muller et al., 2000). A related protein, KSR2, has been
detected in C. elegans and humans (Channavajhala et al., 2003;
Ohmachi et al., 2002). InC. elegans, KSR2 is required for germline
meiotic progression and functions redundantly with KSR1 in
excretion, vulva development, and spicule formation. Thus,
KSR proteins appear to play critical roles in regulating multiple
cell fates.
Cells must sense the nutritional status of the extracellular envi-
ronment, monitor intracellular energy stores, and integrate that
information with intracellular pathways that drive cell fate. The
trimeric AMP-activated protein kinase (AMPK) is a critical regu-
lator of energy homeostasis that is activated when the nutritional
environment is poor and intracellular ATP levels are low (Hardie,
2007). Under conditions of energy stress, ATP levels fall, and
levels of the allosteric activator AMP rise, which promotes
binding of the catalytic AMPK a subunit to the g subunit and
protects against dephosphorylation of a critical threonine in the
activation loop of the a subunit kinase domain (Sanders et al.,
2007). ATP antagonizes the action of AMP on AMPK, making
AMPK a sensor of cellular energy stores.
Upon activation, AMPK stimulates metabolic enzymes and
induces gene expression programs to promote catabolic activity
and inhibit anabolic activity. AMPK stimulates insulin-indepen-
dent glucose uptake in muscle in response to exercise and
hypoxia (Mu et al., 2001), and promotes the b oxidation of long-
chain fatty acids by phosphorylating and inhibiting acetyl-CoA
carboxylase (ACC), the rate-limiting enzyme of malonyl-CoA
synthesis (Ruderman et al., 2003). Malonyl-CoA is both a key
substrate for fatty acid synthesis and an inhibitor of carnitine
palmitoyltransferase 1 (CPT1), which mediates import of fattyr Inc.
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inhibiting ACC, AMPK inhibits the synthesis of fatty acids and
promotes their metabolism to generate ATP.
The mechanisms linking dietary nutrients and AMP-regulated
energy metabolism to cell fate are incompletely understood.
Our analysis of the scaffold KSR2, however, provides a missing
link. Here we show that KSR2 interacts with AMPK in a function-
ally relevant manner in vitro and in vivo. In cultured cells, AMPK-
dependent effects on basal glucose uptake, fatty acid oxidation
(FAO), and glycolysis are enhanced by KSR2. Gene disruption of
ksr2 reduces the glucose-lowering capacity of an AMPK agonist
in vivo. The white adipose tissue of ksr2/ mice demonstrates
defective phosphorylation of the AMPK substrate ACC, a key
regulator of fatty acid synthesis and oxidation, and a downregu-
lation of genes involved in oxidative phosphorylation. As a conse-
quence of these impaired AMPK-dependent mechanisms,
ksr2/ mice are obese and insulin resistant. In contrast to
most other animal models of obesity, ksr2/mice are hypopha-
gic and more active. However, they expend less energy than
wild-type mice. These data reveal a novel role for KSR2 as a
critical regulator of cellular energy balance affecting lipid and
glucose metabolism.
RESULTS
KSR1 and KSR2 Interact with AMPK
Weusedmass spectrometry to identify novel regulators thatmay
affect KSR1 and KSR2 function. Previously reported KSR1-
interacting molecules (Muller et al., 2001; Ory et al., 2003; Ritt
et al., 2007), including HSP90, HSP70, Cdc37, C-Tak1, and
PP2A,weredetected in associationwithKSR2, aswerepeptider-
gic components of the a1, a2, b1, and g1 subunits of AMPK (Fig-
ure 1A). This interaction was verified by the coprecipitation of
endogenous AMPK a1 subunit in immunoprecipitates of KSR2,
but not in immunoprecipitates of KSR1 (Figure 1B). When both
AMPKa and KSR1 were overexpressed, an interaction between
the two proteins could be detected. However, when compared
for their relative ability to precipitate endogenous or ectopic
AMPKa, KSR2 consistently precipitated more AMPK than did
KSR1 (Figure 1C). To determine the sites required for interaction
with AMPK, full-length and truncated versions of KSR1 andKSR2
were expressed in 293TorCOS-7 cells, and their ability to precip-
itate endogenous AMPK or the ectopic AMPKa subunit was
tested. Deletion analysis indicated that the CA3 region contrib-
utes to the interaction of the AMPKa subunit with KSR1 (Fig-
ures 1D and 1E) and that the CA3 region and amino acids unique
toKSR2 interveningbetween theCA2andCA3 region (Dougherty
et al., 2009) eachcontributed to theability of KSR2 to interactwith
the AMPKa subunit (Figures 1F and 1G). The observation that
KSR2 retains additional sequences contributing to its interaction
with AMPK may explain its ability to precipitate a proportionally
greater amount of AMPK.
KSR2 Promotes Glucose and Fatty Acid Metabolism
We tested whether mutations that impaired the interaction of
AMPK with KSR1 or KSR2 affected ERK activation. The DCA3
mutation severely affected maximal activation of ERK by KSR
proteins as observed previously for KSR1 (Michaud et al.,
1997) (Figure 2A and see Figure S2A available online). However,Cell MKSR2D327-392 effects on ERK activation were equivalent to
KSR2 (Figure 2A). These data indicate it is unlikely ERK activation
plays a role in mediating the effects of KSR2 on AMPK signaling.
AMPK stimulates glucose uptake and the oxidation of fatty
acids bymitochondria, thereby promoting ATP synthesis (Ruder-
man et al., 2003). To test whether KSR proteins affect these
catabolic functions of AMPK, we generated ksr2/ mice (Fig-
ure S1) and ksr2/ mouse embryonic fibroblasts (MEFs). We
measured glucose uptake in ksr2/ and ksr1/ MEFs and in
null MEFs expressing their respective cognate ksr transgenes.
ThoughMEFs do not express detectable KSR2 (data not shown),
expression of ectopic KSR2 in ksr2/ MEFs increased basal
glucose uptake 5-fold (Figure 2B), and expression of KSR1 in
ksr1/ MEFs increased basal glucose uptake 2-fold (Fig-
ure S2B). Deletion of the CA3 region (KSR2.DCA3) modestly
impaired basal glucose uptake, but deletion of sequences
between the CA2 and the CA3 regions (KSR2.D327-392)
decreased KSR2-induced glucose uptake by 50% (Figure 2B).
Deletion of the CA3 region (KSR1.DCA3) was sufficient to signif-
icantly disrupt the effects of KSR1 on basal glucose uptake
(Figure S2B).
We then tested whether KSR2 or KSR1 affected cellular fatty
acid metabolism. The rate of oxygen consumption (OCR) was
used as an index of oxidative phosphorylation (Wu et al., 2007).
OCR in ksr2/ or ksr1/ MEFs was compared to OCR in
ksr2/ or ksr1/ MEFs expressing full-length KSR2 or KSR1,
respectively. In both ksr2/ and ksr1/ MEFs, palmitate had
little or no ability to stimulate oxygen consumption. However,
the reintroduction of KSR2 (Figure 2C) or KSR1 (Figure S2C)
restored oxidation of palmitate. As with glucose uptake, disrupt-
ing the interaction of KSR2 or KSR1 with AMPK prevented
restoration of FAO (Figure 2C and Figure S2C).
The neuroblastoma X glioma hybrid cell line NG108-15
expresses endogenous KSR2 (Dougherty et al., 2009). An shRNA
was constructed to knock down KSR2 expression in these cells.
In culture, neuronal cell lines in general, and NG108-15 cells in
particular, synthesize ATP primarily from glycolysis (Ray et al.,
1991). Since AMPK activation promotes glycolysis (Marsin
et al., 2000), we examined the ability of KSR2 knockdown with
and without the coexpression of a constitutively active AMPK
construct to regulate glycolysis in NG108-15 cells. As an index
of lactate production, extracellular acidification was markedly
reduced in these cells when RNAi was used to inhibit KSR2
expression. However, expression of a constitutively active
AMPK (Stein et al., 2000) restored glycolysis to levels seen in
control cells (Figure 2D).
Phosphorylation of Thr172 on the effector loop of AMPK
promotes its activity (Stein et al., 2000). In MEFs, the presence
or absence of KSR2 did not affect AMPK Thr172 phosphoryla-
tion (data not shown), suggesting that AMPK signaling may
require KSR2 for proper spatial regulation similar to its effect
on ERK (Dougherty et al., 2009). However, in NG108-15 cells,
loss of KSR2 inhibits the phosphorylation of AMPK on Thr172
in response to AICAR and modestly impairs phosphorylation of
the AMPK substrate ACC (Figure 2E). These data support the
conclusion that KSR2 is an AMPK regulator. To determine the
relative impact of KSR1 and KSR2 on AMPK function and fatty
acid metabolism in vivo, we examined the metabolic phenotype
of ksr1/ and ksr2/ mice.etabolism 10, 366–378, November 4, 2009 ª2009 Elsevier Inc. 367
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Figure 1. KSR1 and KSR2 Interact with AMPK
(A) AMPK-related peptides detected from endogenous proteins coprecipitating with KSR2. KSR2-associated proteins were isolated and peptide fragments were
detected by mass spectrometry.368 Cell Metabolism 10, 366–378, November 4, 2009 ª2009 Elsevier Inc.
Cell Metabolism
KSR2 Regulates AMPK and Energy ExpenditureLoss of ksr2 Causes Obesity
KSR2 protein is detectable by western blot only in brain
(Figure S1C). Therefore, we determined the relative abundance
of ksr2 mRNA in various tissues (Figure 3A). Consistent with
western blot analysis, ksr2 mRNA is approximately 100-fold
more abundant in brain than in skeletal muscle or liver. ksr2
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Figure 2. KSR1 Expression Regulates
Metabolism in Mouse Embryonic Fibro-
blasts
(A) ERK activation in WT MEFs and ksr2/ MEFs
expressing the indicated constructs were treated
with 25 ng/ml of PDGF for the indicated times,
and phosphoERK was detected in situ. Represen-
tative expression of each construct is shown.
Results are the mean ± SD of triplicate determina-
tions.
(B) Glucose uptake in ksr2/ MEFs and ksr2/
MEFS expressing KSR2, KSR2.DCA3, or
KSR2.D327-392.
(C) FAO in ksr2/ MEFs expressing the indicated
constructs.
(D) Glycolysis in NG108-15 cells expressing a non-
targeting shRNA, or an shRNA against KSR2 with
or without a vector encoding constitutively active
AMPK (AMPK-CA). n = 8 for each condition.
(E) NG108-15 cells expressing a nontargeting
shRNA, or an shRNA against KSR2, were treated
with 0–10 mM AICAR for 30 min at 37C.
(B–D) Results are shown as the mean ± SD.
*p < 0.05; **p < 0.01; ***p < 0.001.
mRNA is detectable at low levels in
adipose tissue. In contrast, ksr1 mRNA
is expressed strongly in skeletal muscle
but present at approximately one-third
that level in brain and 5% of that level in
adipose tissue. ksr1/ mice have been
previously reported to have enlarged
adipocytes but normal amounts of all
adipose tissues (Kortum et al., 2005).
Further analysis revealed no altered
response to an AMPK agonist
(Figure S3) and no overt metabolic
defects (Figure S4 and Table S1) in
ksr1/mice.
To test the role of KSR2 in the regulation
ofAMPK-mediated signaling,we targeted
exon 4 within the ksr2 locus for deletion
in mice (Figure S1). The ksr2 null allele
was transmitted through the germline,
and heterozygous intercrosses yielded
all three genotypes in a ratio close to the expected Mendelian
distribution (relative ratios ksr2+/+ 1, ksr2+/ 2.25, ksr2/
0.91; n = 441). During development in utero and at birth,
ksr2/ mice were identical in size and weight to wild-type
and ksr2+/mice (Figure 3B, left panel). However, while nursing,
ksr2/ mice grew at approximately 50% the rate observed in(B) Full-length (FL) and truncated Pyo-tagged KSR1 and KSR2 constructs were expressed in COS-7 cells.
(C) FLAG-tagged KSR1 or KSR2 expressed in 293T cells with the Myc-tagged AMPK a subunit. Cells were left untreated or treated with oligomycin.
(D) Truncated FLAG-tagged KSR1 constructs expressed in 293T cells with the Myc-tagged AMPK a subunit.
(E) Deletion constructs of FLAG-tagged KSR1 and the Myc-tagged AMPK a subunit expressed in 293T cells.
(F) Truncated Pyo-tagged KSR2 constructs were expressed in COS-7 cells.
(G) Pyo-tagged full-length KSR1, KSR2, or KSR2 with a deletion of amino acids 327–392 expressed in COS-7 cells (left panel). FLAG-tagged full-length KSR2 or
KSR2 with a deletion of the CA3 region (DCA3) expressed with the Myc-tagged AMPK a subunit (right panel).
(B–G)Whole-cell lysates and anti-Pyo or anti-FLAG immunoprecipitates were resolved by SDS-PAGE, transferred to nitrocellulose, and probedwith the indicated
antibodies.Cell Metabolism 10, 366–378, November 4, 2009 ª2009 Elsevier Inc. 369
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Figure 3. Targeted Disruption of ksr2 Causes Obesity
(A) Expression of ksr2 (left panel) and ksr1 (right panel) mRNA in white adipose tissue (WAT), brown adipose tissue (BAT), liver, quadriceps (QUAD) and gastroc-
nemius (GASTROC) muscles, and whole brain. The expression of ksr2 and ksr1was normalized relative to the expression of two control genes,GusB and Tbp, in
each tissue.
(B) Null (/), heterozygous (+/), and WT (+/+) mice at day E18.5 (left), 8 days (middle), and 24 weeks (right) of age.
(C) Body weights of null (squares, n = 8) and WT (diamonds, n = 6) mice from 3 to 36 weeks of age. Results are shown as the mean ± SE.
(D) Body weight and body composition of 12-week-old WT (light bars, n = 6 male and 7 female) and ksr2/ (dark bars, n = 5 of each sex) mice.
(E) Wet weight of visceral (VISC), inguinal (ING), subcutaneous (SUB), and brown (BAT) adipose depots inWT (light bars, n = 4) and ksr2/mice (dark bars, n = 5).
(F) Hematoxylin and eosin staining of histological sections from subcutaneous adipose tissue is shown (upper). Adipocyte cross-sectional area (lower) inWT (light
bars) and ksr2/ mice (dark bars).
(G) WT and ksr2/ brain lysates were immunoprecipitated with antibodies to the AMPK a subunit or a nonimmune antibody. Immunoprecipitates and represen-
tative lysates were probed on western blot for expression of KSR2 and AMPKa.
(H) Blood glucose levels at the indicated times in 6- to 7-month oldWT (circles) and ksr2/mice (diamonds) following intraperitoneal injection of 0.25 g/kg AICAR.
Basal blood glucose levels (mg/dl) in fed mice were 139.7 ± 8 (ksr2/ female), 120.7 ± 12 (WT female), 152.8 ± 6 (ksr2/ male), and 151.8 ± 23 (WT male).
n = 8 male, 4 female for each genotype.
(I) Western blot analysis of total and phosphoThr172 AMPK a subunit (upper) and total and phosphoSer79 ACC (lower) from white adipose tissue of WT and
ksr2/ mice 15 min after injection with 0.25 g/kg AICAR. Graphs show the relative phosphorylation of each protein from five independent experiments.
(J) Phosphorylation of AMPK Thr172 and ACC Ser79 in explants of subcutaneous adipose tissue incubated in DMEM at 37C for 16 hr with and without 1 mM
AICAR.
(A, D, E, H, and I) Results are shown as the mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001 by single-factor ANOVA or (I) unpaired, two-tailed t test.wild-type and ksr2+/ mice (Figure 3B, center panel). Thirty-two
percent of ksr2/mice (31 of 98) failed to survive until weaning.
Premature death was not due to the failure of ksr2/ pups to
nurse properly, as all mice had milk in their stomachs upon
necropsy. The addition of foster mothers did not improve
survival. Furthermore, nutrient absorption was identical in370 Cell Metabolism 10, 366–378, November 4, 2009 ª2009 Elsevierwild-type and ksr2/ mice (data not shown). We measured
the growth rate of surviving ksr2/ mice and observed that
the ksr2/ mice attained body weights similar to wild-type
and ksr2+/ mice 6–10 weeks after birth (Figure 3C). At 20–24
weeks of age, ksr2/ mice exceeded the body weight of their
wild-type and ksr2+/ littermates and became obese (Figure 3B,Inc.
Cell Metabolism
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a doubling in fat mass and a 15% decrease in lean mass even
before body weight differences became apparent (Figure 3D).
All adipose depots from ksr2/ mice were significantly
increased in mass relative to wild-type mice (Figure 3E). Histo-
logical analysis demonstrated that the cross-sectional area of
adipocytes from white adipose tissue in ksr2/ mice was
increased in size relative to wild-type mice (Figure 3F).
ksr2 Promotes AMPK Signaling In Vivo
We tested whether an interaction between endogenous KSR2
and AMPK could be detected similar to that observed when
KSR2was overexpressed in COS-7 cells (Figure 1). Brain lysates
from wild-type and ksr2/ mice were precipitated with anti-
bodies against the AMPKa subunit and probed for KSR2 on
western blot. KSR2was detected in anti-AMPKa immunoprecip-
itates from WT brain but not detected in anti-AMPKa immuno-
precipitates from ksr2/ brain or from wild-type brain immuno-
precipitated with a nonimmune antibody (Figure 3G).
To determine whether ksr2/ mice have defects in AMPK
signaling, we tested the ability of an intraperitoneal injection of
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Figure 4. ksr2/ Mice Are Hypothermic
and Hypophagic
(A) Hematoxylin and eosin staining of BAT from
WT (left) and ksr2/ (right) mice.
(B) Rectal temperature in 5- to 6-month-old male
and female WT (light bars, n = 8 for each sex)
and ksr2/ mice (dark bars, n = 6 males, n = 11
females) during light (1 p.m.) and dark (9 p.m.)
cycles (left panel).
(C) UCP1 mRNA levels in BAT (left panel) in 9- to
10-month female WT (light bars, n = 11) and
ksr2/ mice (dark bars, n = 5). UCP1 protein
levels (right panel) in 8-month-old WT and ksr2/
female mice.
(D) Average daily food intake in six WT males
(age 11.5 ± 1.0 weeks), seven WT females
(age 10.6 ± 1.1 weeks), five ksr2/ males (age
11.4 ± 0.6 week), and five ksr2/ females (age
10.5 ± 1.0 week).
(E) Serum leptin concentrations in 5- to 6-month-
old WT and ksr2/ mice.
(F) Twenty-four hour food intake following
control PBS or 5 mg/kg leptin injections in WT
and ksr2/ mice. n = 5 for each genotype.
(G) Neuropeptide mRNA expression in 8- to
9-month-old female WT and ksr2/ mice. n = 7
for each genotype.
(B–G) Results are shown as the mean ± SD.
*p < 0.05; **p < 0.01; ***p < 0.001.
the AMPK agonist AICAR to lower blood
glucose. Wild-type mice showed a rapid
and sustained reduction in blood glucose
in response to the AMPK agonist AICAR
that was not altered by deletion of ksr1
(Figure S3). However, disruption of ksr2
in mice delayed the onset of the drop in
blood glucose and reduced the extent
of the decrease (Figure 3H). Given the
effect of AICAR in ksr2/mice, the phos-
phorylation state of AMPK and ACC was examined in white
adipose tissue. While wild-type mice showed strong phosphor-
ylation of AMPK and ACC following AICAR injection, disruption
of ksr2 impaired their phosphorylation in white adipose tissue
(Figure 3I). Furthermore, when explants of subcutaneous
adipose tissue were isolated and incubated ex vivo with AICAR,
wild-type adipose tissue showed robust phosphorylation of
AMPK on Thr172 and of ACC on Ser79. However, AMPK and
ACC from ksr2/ adipose tissue remained unphosphorylated,
and ACC expression was markedly reduced (Figure 3J).
These data suggest that, despite its low level of expression (Fig-
ure 3A), KSR2 functions in a cell-autonomous manner in adipose
tissue.
KSR2 Controls Energy Expenditure
We next tested the hypothesis that due to the role of KSR2 in
controlling AMPK function, global ksr2 gene disruption would
result in impaired energy metabolism. Large lipid vesicles were
detected in the brown adipose tissue (BAT) of ksr2/ mice
that were absent in wild-type mice (Figure 4A). BAT is the major
site of adaptive thermogenesis in rodents, and adaptiveCell Metabolism 10, 366–378, November 4, 2009 ª2009 Elsevier Inc. 371
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regulates energy balance to compensate for alterations in
nutrient intake (Lowell and Spiegelman, 2000). We next as-
sessed whether this lipid accumulation was reflected in reduced
heat generation. The rectal temperature of wild-type and ksr2/
mice was compared during distinct diurnal periods. Deletion of
KSR2 lowered rectal temperature by as much as 1.5C
(Figure 4B) and modestly decreased UCP1 mRNA expression
(Figure 4C, left panel) and protein levels (Figure 4C, right panel).
Hyperphagia is considered a hallmark of numerous well-
characterized rodent models of obesity (Bray and York, 1979).
However, obese ksr2/ mice actually consumed less food
than wild-type mice in spite of increased adiposity (Figure 4D).
Consistent with the observed increase in fat mass, serum leptin
levels in the ksr2/ mice were elevated 7-fold in females and
12-fold in males (Figure 4E). The morbid obesity and hyperlepti-
nemia suggested massive leptin resistance. However, injection
of leptin suppressed food consumption to the same degree in
both wild-type and ksr2/ mice (Figure 4F). Key orexigenic
hypothalamic neuropeptides agouti-related peptide (AgRP) and
neuropeptide Y (NPY) (Ollmann et al., 1997; Schwartz et al.,
1996), and anorexigenic neuropeptides proopiomelanocortin
(POMC) and cocaine- and amphetamine-regulated transcript
(CART) (Kristensen et al., 1998) were unchanged in ksr2/
mice, suggesting a novel compensatory mechanism indepen-
dent from known major pathways of adipocyte-hypothalamus
communication (Figure 4G).
Consistent with the ability of KSR2 to alter the rate of oxygen
consumption in vitro (Figure 2D), youngmale ksr2/mice in total
consume less oxygen than wild-typemice and produce less CO2
(Figure 5A). In females, a similar trend is observable. These data
support the conclusion that oxidative phosphorylation is
impaired by the disruption of ksr2. Respiratory quotient (RQ) is
lower in ksr2/ mice during the dark cycle relative to wild-type
mice (Figure 5A and Figure S5A), indicating a preference for fatty
acids as metabolic substrate of choice or a relative resistance to
carbohydrate metabolism during active periods. General, ambu-
latory, and stationary motor activity is increased in ksr2/ mice
(Figure 5B and Figures S5B–S5D), despite their obesity. The
consequence of such energy balance physiology responses to
the disruption of ksr2 would result in a decreased amount of
energy stored as fat. However, overall ksr2/ mice expend
substantially less energy (Figures 5C) and therefore accrue larger
fat deposits than wild-type mice. In order to exclude a potential
artifact resulting from relative cold exposure of ksr2/ and wild-
type mice while being studied at room temperature, we reana-
lyzed their metabolic phenotype at thermoneutrality (32C).
ksr2/ mice exhibited significantly lower oxygen consumption
under those conditions (Figure 5D), consistent with an ambient
temperature-independent and physiologically relevant deficit in
basal metabolic rate. Thus, despite compensatory feeding and
nutrient partitioning responses to their increased adiposity,
ksr2/ mice become obese due to low resting thermogenesis
and high energy efficiency.
ksr2/ Mice Are Insulin Resistant
Obesity is associated with elevated serum lipids and predis-
poses rodents and humans to impaired glucose homeostasis
(Lazar, 2005). We find that the absence of KSR2 replicates372 Cell Metabolism 10, 366–378, November 4, 2009 ª2009 Elsevierboth conditions, since ksr2/ mice show elevated lipolysis,
free fatty acids, triglycerides (Figure 6A), and fasting insulin levels
(Figure 6B). Adiponectin, resistin, PAI-1, IGF-1, and thyroxin
were not significantly altered by disruption of ksr2. MCP-1 was
significantly elevated in male but not female ksr2/ mice
(Figure S6). These data suggested that elevated endogenous
insulin levels might be compensating for peripheral insulin resis-
tance caused by the disruption of ksr2. We therefore performed
hyperinsulinemic euglycemic clamps on wild-type, ksr1/, and
obese ksr2/ mice. Glucose homeostasis in ksr1/ mice
mirrored that of wild-type mice (Table S1). In contrast, ksr2/
mice maintained comparable blood glucose concentrations
only at glucose infusion rates that ranged between 20%–50%
of that observed in wild-type mice (Figure 6C). Though hepatic
glucose production (HGP) was reduced in ksr2/ mice in
comparison to wild-type mice, the ability of insulin to suppress
HGP in the null mice wasmarkedly suppressed (Figure 6D). Simi-
larly, whole-body glucose turnover, glycolysis, and glycogen
production were reduced in knockout mice (Figure 6E). These
data are consistent with markedly reduced glycogen content in
the livers and glycolytic muscle of ksr2/ mice (Figure 6F). To
estimate insulin-stimulated glucose uptake in individual tissues,
2-deoxy-D-[1-14C] glucose was administered as a bolus (10mCi)
75 min after the start of clamp. In comparison to wild-type mice,
ksr2/ mice showed profound insulin resistance in skeletal
muscle (gastrocnemius) and both white (epididymal) and brown
adipose tissue (Figure 6G). In combination with the effect on
HGP, these data reveal that disruption of ksr2 impairs glucose
uptake at the major sites of insulin action.
To test whether the effect of KSR2 disruption had a cell-auton-
omous effect on insulin-stimulated glucose uptake, we exam-
ined glucose uptake in isolated EDL muscles from wild-type
and ksr2/mice. Insulin significantly stimulated glucose uptake
in the isolated muscle from either genotype to a similar degree
(Figure 6H). In contrast, the AMPK agonist AICAR had a small
but significant impact on glucose uptake in wild-type EDL
muscle but no effect on EDL muscle from ksr2/ mice. These
data suggest that KSR2 has a direct effect on AMPK-stimulated
glucose uptake in EDL muscle. However, the insulin resistance
observed in skeletal muscle of ksr2/ mice appears to be
a non-cell-autonomous effect, perhaps secondary to the obesity
and impaired lipid metabolism caused by KSR2 disruption
(Bergman et al., 2006).
KSR2 Coordinates OXPHOS Gene Expression
The observation that KSR2 expression regulated oxidative
metabolism in vitro (Figure 2C) led us to examine gene expres-
sion in the white adipose tissue of ksr2/ and wild-type mice.
Gene Set Enrichment Analysis (GSEA) (Subramanian et al.,
2005) revealed that gene sets previously identified as downregu-
lated in obese mouse models and in some humans with
abnormal glucose tolerance are regulated by ksr2 (Figure S7A,
Table S2). Strongest among these was a gene set previously
shown to be downregulated in ob/ob mice (Nadler et al., 2000).
A notable number of sets that included genes for oxidative
metabolism were also downregulated in ksr2/ mice. A subset
of oxidative phosphorylation genes coregulated across different
mouse tissues (OXPHOS-CR) was identified previously (Mootha
et al., 2003). This gene set corresponds to two-thirds of theInc.
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Figure 5. ksr2/ Mice Are More Active but Expend Less Energy Than WT Mice
(A) Oxygen consumption (left), carbon dioxide production (middle), and RQ (right) in WT and ksr2/ mice.
(B) Cumulative locomotor activity in WT and ksr2/ mice.
(C) Spontaneous (middle) and cumulative (right) energy expenditure in male and female WT and ksr2/ mice.
(D) Oxygen consumption (upper panel) and core body temperature of female WT and ksr2/ mice at 32C.
(A–D) Six WT males (age 11.5 ± 1.0 weeks), seven WT females (age 10.6 ± 1.1 weeks), five ksr2/ males (age 11.4 ± 0.6 week), and five ksr2/ females (age
10.5 ± 1.0 weeks). (D) Four WT (age 30.7 ± .02 weeks) and three ksr2/ (32.6 ± .07 weeks) female mice. (A–D) Results are shown as the mean ± SD. *p < 0.05;
**p < 0.01; ***p < 0.001, unpaired, two-tailed t test or (C) two-way ANOVA with Bonferroni’s post hoc test.genes encoding the oxidative phosphorylation biochemical
pathway. The OXPHOS-CR gene set is reported to be downre-
gulated in skeletal muscle of some humans with impaired
glucose tolerance and correlated with changes in total body
metabolism. We examined the expression of a custom gene
set corresponding to the mouse orthologs (mOXPHOS-CR)
and determined that this set was significantly downregulated
(p < 0.001, NES=2.39, FDR < 0.001) in thewhite adipose tissueCell Mof ksr2/ mice. Eighty-three percent (20 of 24) of the genes
demonstrated lower expression in ksr2/ mice in comparison
to wild-type mice (Figure S7). The transcriptional coregulator
PGC1a is a potent regulator of OXPHOS-CR genes (Mootha
et al., 2003). Microarray analysis revealed that PGC1a is also
markedly decreased in the white adipose tissue of ksr2/
mice (Figure S7). These data demonstrate that the AMPK regu-
lator KSR2 plays a potent role in controlling the expression ofetabolism 10, 366–378, November 4, 2009 ª2009 Elsevier Inc. 373
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contribute to impaired glucose tolerance in ksr2/ mice.
DISCUSSION
In this study, we show that the molecular scaffold KSR2 is an
essential regulator of AMPK activity controlling cellular thermo-
genesis, fat oxidation, and glucose metabolism. These data
suggest a model (Figure 7) whereby a decrease in AMPK
function impairs FAO and increases lipid storage, contributing
to obesity and insulin resistance in ksr2/ mice. In wild-type
mice, KSR2 interacts with AMPK to negatively regulate ACC
and promote the expression of PGC1a-dependent OXPHOS
genes. Inhibition of ACC prevents the synthesis of the CPT1 allo-
steric negative regulator malonyl CoA. Together with OXPHOS
gene expression, elevated CPT1 activity enhances the oxidation
of fatty acids and reduces their storage as triglycerides (TG). In
the absence of KSR2, AMPK function is impaired, OXPHOS
gene expression declines, and ACC activity is deregulated,
A B
DC
E F
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H
Figure 6. Lipid, Glucose, and Insulin
Homeostasis Is Disrupted in ksr2/ Mice
(A) Lipolysis (left), serum concentrations of nones-
terified free fatty acids (middle), and triglycerides
(right) in 5- to 6-month-old WT (n = 5, left; n = 4,
middle; n = 7, right) and ksr2/ mice (n = 6, left;
n = 3, middle; n = 4, right).
(B) Fasting serum insulin in 5- to 6-month-old WT
(light bars, n = 8) and ksr2/ mice (dark bars,
n = 8).
(C–E) (C) Glucose infusion rate, (D) hepatic glucose
production and hepatic insulin action, (E) glucose
turnover, glycolysis, and glycogen/lipid synthesis
in WT (n = 11) and ksr2/ mice (n = 8).
(F) Tissue glycogen from liver (left) and gastrocne-
mius (right) in 5- to 6-month-old WT and ksr2/
mice.
(G) Glucose uptake in skeletal muscle, white
adipose tissue, and BAT in WT (n = 11) and
ksr2/ mice (n = 8).
(H) Ex vivo glucose uptake in isolated EDL muscle
from WT and ksr2/ mice treated with 100 nM
insulin (left panel, n = 6 WT, 3 ksr2/) or 2 mM
AICAR (right panel, n = 5 WT, 5 ksr2/).
(A–H) Results are shown as the mean ± SD.
*p < 0.05, **p < 0.01, ***p < 0.001.
causing decreased long-chain fatty acid
uptake into mitochondria via CPT1 and
enhanced triglyceride synthesis, which
promotes obesity. These findings reveal
a novel pathway regulating energy
expenditure and glucose metabolism,
the elucidation of which may facilitate
therapeutic intervention in obesity.
It remains unclear to what extent
specific tissues contribute to the meta-
bolic defects caused by KSR2 disruption.
Ex vivo experiments suggest a role for
KSR2 in adipose tissue and muscle.
However, KSR2 is detectable by western
blot only in the brain, and mRNA profiling detects much lower
levels of KSR2 in muscle, liver, and adipose tissue. These data
suggest that important actions of KSR2 on AMPK are probably
exerted within the central nervous system.
Resting metabolic rate is the major contributor to obligatory
energy expenditure and is strongly associated with fat-free
mass (Cunningham, 1991). However, fat-free mass accounts for
only 70%–80% of the variability in resting metabolic rate (Sparti
et al., 1997). Genetically determined differences in the ability of
organisms to consumeoxygen tomakeATPhavebeenproposed
as an explanation for at least some of the remaining variability
(Harper et al., 2008). The reduced oxygen consumption and
energy efficiency of ksr2/mice identify ksr2 as a novel genetic
determinant ofmetabolic rate. To someextent, decreasedenergy
expenditure in ksr2/mice could be ascribed to the decrease in
UCP1 expression, which might contribute to the 1.5C drop in
rectal temperature of ksr2/mice. The reduced rectal tempera-
ture of ksr2/ mice therefore suggests that ksr2 is essential for
the physiological regulation of resting thermogenesis.374 Cell Metabolism 10, 366–378, November 4, 2009 ª2009 Elsevier Inc.
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in determining whether fatty acids are oxidized in mitochondria
to generate ATP or are stored as triglycerides. Our in vivo and
ex vivo data demonstrate that deletion of KSR2 in white adipose
tissue impairs the ability of AMPK to phosphorylate ACC, which
should inhibit FAO and promote triglyceride storage (Ruderman
et al., 2003). This defect provides a simple explanation for the
increased fat mass of ksr2/ mice (Brommage et al., 2008).
Accordingly, ampka2/ mice share traits with ksr2/ mice.
On a high-fat diet, ampka2/ mice demonstrate elevated
body weight, morbidly increased adipose mass, and adipocyte
hypertrophy without an increase in food intake relative to control
mice (Villena et al., 2004). Similar to ksr2/mice, deletion of the
AMPK a2 subunit causes insulin resistance and AICAR intoler-
ance (Viollet et al., 2003). Also consistent with our findings,
loss of AMPK signaling that results from hepatic disruption of
the AMPK kinase, LKB1, causes hyperglycemia and glucose
intolerance while not impairing insulin action (Shaw et al.,
2005). Thus, KSR2 may affect cell-autonomous energy homeo-
stasis in multiple tissues by directly modulating lipid and glucose
metabolism via AMPK, while behavioral phenotypes of KSR-
deficient mice such as hypophagia and hyperactivity are likely
compensatory responses for body set point defense.
We performed microarray analysis on mRNA isolated from
wild-type and ksr2/adipose tissue to identify genetic pathways
affected by the deletion of KSR2. GSEA of microarray data iden-
tified curated gene sets that are significantly regulated by the
presence or absence of KSR2 (Figure S7 andTable S2).Grouping
the highest ranking (p = 0.000; FDR % 0.001; FWER % 0.045)
gene sets according to overlapping genes identifies three general
cellular functions regulated by KSR2. In white adipose tissue,
KSR2appears tomost potently affect genes regulating adipocyte
differentiation, genes involved in oxidative phosphorylation, and
genes affecting the metabolism of branched-chain amino acids
and short-chain lipids. KSR2-dependent regulation of genes
controlling adipocyte differentiation (e.g., Nadler Obesity Down,
IDX TSA Up Cluster 6, and TNFa Down gene sets) plays a role
in the increased adipocyte cell number observed in ksr2/
mice. Decreased expression of genes involved in oxidative
phosphorylation (e.g., Electron Transport, Mootha VoxPhos,
and Mitochondria gene sets) likely contributes to the decreased
Figure 7. A Model of KSR2-Mediated Regulation of Metabolism
Arrows indicate activation. Lines with perpendicular bars attached indicate
inhibition. Dashed lines denote decreased function or expression. Arrowheads
denote corresponding changes in the amount or activity of the indicated mole-
cule. See text for details.Cell Mability of ksr2/ mice to metabolize lipid and carbohydrate.
Gene sets for branched chain amino acid catabolism and propi-
onate, butanoate, and pyruvate metabolism represent key path-
ways that generate key substrates (e.g., acetyl-CoA, succinyl-
CoA) to the TCA cycle and fatty acid synthesis. The regulation
of these pathways by KSR2 suggests a role for the scaffold in
controlling both the availability of these key substrates and the
enzymes necessary for their metabolism. However, future exper-
iments will be required to determine whether these changes in
gene expression are mediated by the action of KSR2 in adipose
tissue or in another tissue with prominent expression, like the
brain.
KSR1 and KSR2 are best known for their function as scaffolds
for the Raf/MEK/ERK signaling cassette, facilitating the activa-
tion of Raf and MEK (Dougherty et al., 2009; Kortum and Lewis,
2004; Nguyen et al., 2002). The interaction of AMPK with these
molecular scaffolds raises the intriguing possibility that KSR
proteins function not only as scaffolds, but also as components
of an energy and nutrient sensor that couples information about
the nutritional environment and intracellular energy status of
a cell to a kinase cascade with potent effects on cell proliferation,
differentiation, and survival. The discovery that C-TAK1/MARK3/
Par1a, a member of the AMPK kinase family, phosphorylates
KSR1 and inhibits its ability to promote the activation of MEK
by Raf (Muller et al., 2001) supports this concept. In complex
with KSR2, AMPK might provide similar means to restrict
energy-intensive proliferative stimuli emanating from activated
ERK when ATP is limited. ksr2/ mice might thus develop
impaired metabolic homeostasis due to an inability to respond
appropriately to energy deficits and curb ERK signaling when
the nutritional environment is inadequate.
Consistent with that paradigm, our results demonstrate that
disruption of ksr2 causes obesity through a reduction in cellular
energy consumption despite hypophagia. Therefore, our obser-
vations reveal ksr2/ mice to be a novel model of obesity with
potential relevance to obesity-related dysregulation of glucose
metabolism. That molecular scaffolds regulating the activation
of Raf, MEK, and ERK can have a profound effect on fat accumu-
lation suggests that factors affecting energy balance may have
previously unappreciated roles on MAP kinase signaling. In
particular, future studies focusing on cell-type-specific mecha-
nisms of KSR2/AMPK interactionsmay provide important insight
into novel mechanisms regulating physiological control of energy
storage and expenditure with implications for glucose homeo-
stasis.
EXPERIMENTAL PROCEDURES
Mice
ksr1/ mice were described previously (Kortum et al., 2005; Nguyen et al.,
2002). Standard gene-targeting techniques and homologous recombination
were used to generate ksr2/ mutant mice. The Institutional Animal Care
and Use Committee (University of Nebraska Medical Center, Omaha, NE)
approved all studies. Animals were maintained on a 12 hr light/dark schedule
(light on at 0600) and had free access to laboratory chow (Harlan Teklad LM
485) and water. All in vivo analyses were performed on mice of 3–7 months
of age.
Cells
ksr1/ and ksr2/MEFs were generated from day 13.5 embryos and immor-
talized by 3T9 protocol as described (Kortum and Lewis, 2004) or byetabolism 10, 366–378, November 4, 2009 ª2009 Elsevier Inc. 375
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sponding mutants in MEFs was also measured as described previously (Kor-
tum and Lewis, 2004). NG108-15 cells, COS-7, and 293T cells were obtained
from ATCC.
Immunoprecipitation and Immunoblots
Immunoprecipitation was performed on postnuclear membranes with anti-
bodies to the FLAG, Pyo, and Myc epitope tags as described previously
(Kortum and Lewis, 2004; Ritt et al., 2007). Antibodies for AMPKa, phospho-
Thr172 AMPK, ACC, and phospho-Ser79 ACC, UCP1, and GAPDH were
from Cell Signaling Technologies. Anti-KSR2 antibody 1G4 was from Abnova.
Anti-a-tubulin antibodies were from Santa Cruz.
Glucose Uptake and ERK Assays
Glucose uptakewasmeasuredwith 2-deoxy-D[2,6-3H]glucose in the presence
or absence of 20 mM cytochalasin B and 200 mM phloretin as described previ-
ously (Chaika et al., 1999). ERKphosphorylationwasquantified on theOdyssey
system (LI-COR) with anti-phospho-ERK1/2 (Cell Signaling No. 9106) and anti-
ERK1 (Santa Cruz Biotechnology, sc-93) primary antibodies and goat anti-
mouse Alexa Fluor 680 (Invitrogen) and goat anti-rabbit IRDye 800 (Rockland)
as secondary antibodies as described (Kortum and Lewis, 2004).
Fatty Acid Oxidation and Glycolysis Assays
FAO and glycolysis were determined by measuring OCR and extracellular
acidification rate, respectively, in cultured cells using the XF24 Analyzer (Sea-
horse Bioscience) (Wu et al., 2007).
KSR2 shRNA
A short hairpin targeting the nucleotides for amino acids 868–874 of mouse
KSR2 was cloned into the lentiviral MISSION pLKO.1-puro vector. Puro-
mycin-resistant cells were selected using 2 mg/ml puromycin (Sigma).
ksr1 and ksr2 mRNA Quantification
Total RNA was isolated from selected mouse tissues using Tri-Reagent
(Molecular Research Center, Inc). ksr1, ksr2, GusB, and Tbp were simulta-
neously quantified from 5 mg of total RNA using QuantiGene 2.0 Plex gene
sets (Panomics), following the manufacturer’s recommendations. Total RNA
was hybridized to custom probe set 21121 for 24 hr at 54C while shaking at
900 RPM with an orbital diameter of 3 mm before signal amplification and
quantification using a Luminex 200 instrument. The median fluorescent inten-
sity of at least 50 beads was used to determine the average gene expression
for tissue samples from three mice performed in duplicate.
Quantitiative PCR
RNA was extracted from BAT and hypothalamus using TRizol reagent
(Invitrogen) according to the manufacturers’ instructions. After subsequent
DNase treatment, reverse transcriptions were performed using SuperScript
III (Invitrogen) and Oligo-dT20 primers (Invitrogen). Real-time PCR for UCP1
in BAT and neuropeptides in hypothalamus, and the ribosomal housekeeping
gene L32were performed on aBio-Rad iCycler using iQSYBRGreenSupermix
(Biorad). Relative quantification of the target transcript in comparison to a refer-
ence transcript was calculated from the real-time PCR efficiencies and the
crossing point deviation of the target sample versus its control (Pfaffl, 2001).
Body Composition and Adipocyte Size
Body composition was measured using nuclear magnetic resonance tech-
nology (NMR, EchoMRI, Quantitative Magnetic Resonance Body Composition
Analyzer, EchoMedical Systems, LLC, Houston, TX). Total adipose tissue from
each depot was excised, and the wet weight was determined. Abdominal,
subcutaneous, and BAT were fixed in Bouin’s fixative, sectioned in a micro-
tome, and stained with hematoxylin and eosin. Adipocyte cross-sectional
area was determined from photomicrographs of epididymal fat pads using
IPLab software (Scanalytics Inc., Fairfax, VA) (Kortum et al., 2005).
In Vivo Metabolic Phenotype Analysis
Food intake was measured daily manually over 5 consecutive days in freely
feeding mice. Total energy expenditure, locomotor activity, and RQ (relative
rates of carbohydrate versus fat oxidation) of micewere determined by indirect376 Cell Metabolism 10, 366–378, November 4, 2009 ª2009 Elseviercalorimetry using a customized 32 cage indirect calorimetry system (TSE
Systems, Midland, MI). The mice were placed in the calorimetry system cages
for up to 6 days and nights, with at least 24 hr for adaptation before data
recording. For oxygen consumption measurements at thermoneutral condi-
tions, the environmental temperature requiring the least energy for organismal
heating or cooling processes was determined using indirect calorimetry within
a climate control system. Thermoneutral zone for ksr2/ and wild-type mice
was determined. Oxygen consumption analysis was then performed to ascer-
tain that the thermogenetic phenotype was not an artifact resulting from
relative cold exposure of ksr2/ and wild-type mice.
Metabolite Assays
Blood glucosewasmeasuredwith an Ascensia Glucometer Elite (Fisher Scien-
tific). Plasma insulin was measured with the Mouse Insulin Elisa Kit (Chrystal-
Chem, Chicago, IL) using mouse standards. Serum-free fatty acids were
measured colorimetrically (Roche). Plasma triglycerides and glycerol were
measured using the GPO-Trinder colorimetric assay kit (Sigma). Plasma leptin
was measured using the Rat Leptin RIA kit (Linco Research, St Louis, MO).
Glycogen content was analyzed with the Glucose HK assay (Sigma). For
measurement of lipolysis, mice were fasted overnight for 12 hr. Subcutaneous
fat was excised and minced in Krebs-Ringer bicarbonate buffer at 37C for
3 hr, and a sample of media was assayed for glycerol content using Free
Glycerol Reagent (Sigma).
Ex Vivo Culture of White Adipose Tissue Explants
Subcutaneous fat padswere removed from 7-month-old wild-type and ksr2/
mice, prepared, and treated as described (Gaidhu et al., 2009).
Ex Vivo Glucose Uptake
Glucose uptake was measured in isolated EDL muscle from wild-type and
ksr2/mice using 2-deoxy-D[2,6-3H]glucose and [14C]mannitol as described
previously (Sakamoto et al., 2005).
Statistical Analysis
Data are expressed as mean ± sem. Differences between two groups were
assessed using the unpaired two-tailed t test and among more than two
groups by analysis of variance (ANOVA).
ACCESSION NUMBERS
The microarray data have been deposited at the National Center for Biotech-
nology Information (NCBI) under Gene Expression Omnibus (GEO) accession
number GSE17923.
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www.cell.com/cell-metabolism/supplemental/S1550-4131(09)00298-8.
ACKNOWLEDGMENTS
We thank the members of the Lewis laboratory for comments and criticism.
M. Birnbaum (University of Pennsylvania) is thanked for his gift of the constitu-
tively active AMPK construct. This work was supported by National Institutes
of Health (NIH) grants to R.E.L. (DK52809) and M.H.T. (DK69987, DK59630,
and DK56863) and by support from the Nebraska Research Initiative (to
R.E.L.). M.R.F was supported by the Skala Fellowship, and M.B. was sup-
ported by the Bukey Fellowship from the University of Nebraska Medical
Center (UNMC). K.F. was supported by a Physician/Scientist Training Award
from the American Diabetes Association. The UNMC Microarray Core Facility
receives partial support from NIH grant P20 RR016469. For those studies con-
ducted at United States Army Research Institute Environmental Medicine
(USARIEM), the opinions or assertions contained herein are the private views
of the author(s) and are not to be construed as official or reflecting the views of
the Army or the Department of Defense. Any citations of commercial organiza-
tions and trade names in this report do not constitute an official Department ofInc.
Cell Metabolism
KSR2 Regulates AMPK and Energy Expenditurethe Army endorsement of approval of the products or services of these
organizations.
Received: December 19, 2008
Revised: July 7, 2009
Accepted: September 3, 2009
Published: November 3, 2009
REFERENCES
Bergman, R.N., Kim, S.P., Catalano, K.J., Hsu, I.R., Chiu, J.D., Kabir, M.,
Hucking, K., and Ader, M. (2006). Why visceral fat is bad: mechanisms of
the metabolic syndrome. Obesity (Silver Spring) 14 (Suppl 1), 16S–19S.
Bray, G.A., and York, D.A. (1979). Hypothalamic and genetic obesity in exper-
imental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59,
719–809.
Brommage, R., Desai, U., Revelli, J.P., Donoviel, D.B., Fontenot, G.K.,
Dacosta, C.M., Smith, D.D., Kirkpatrick, L.L., Coker, K.J., Donoviel, M.S.,
et al. (2008). High-throughput screening of mouse knockout lines identifies
true lean and obese phenotypes. Obesity (Silver Spring) 16, 2362–2367.
Burack, W.R., and Shaw, A.S. (2000). Signal transduction: hanging on a
scaffold. Curr. Opin. Cell Biol. 12, 211–216.
Chaika, O.V., Chaika, N., Volle, D.J., Hayashi, H., Ebina, Y., Wang, L.M.,
Pierce, J.H., and Lewis, R.E. (1999). Mutation of tyrosine 960 within the insulin
receptor juxtamembrane domain impairs glucose transport but does not
inhibit ligand-mediated phosphorylation of insulin receptor substrate-2 in
3T3-L1 adipocytes. J. Biol. Chem. 274, 12075–12080.
Channavajhala, P.L., Wu, L., Cuozzo, J.W., Hall, J.P., Liu, W., Lin, L.L., and
Zhang, Y. (2003). Identification of a novel human kinase supporter of Ras
(hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling.
J. Biol. Chem. 278, 47089–47097.
Cunningham, J.J. (1991). Body composition as a determinant of energy expen-
diture: a synthetic review and a proposed general prediction equation. Am.
J. Clin. Nutr. 54, 963–969.
Dougherty, M.K., Ritt, D.A., Zhou, M., Specht, S.I., Monson, D.M., Veenstra,
T.D., and Morrison, D.K. (2009). KSR2 is a calcineurin substrate that promotes
ERK cascade activation in response to calcium signals. Mol. Cell 34, 652–662.
Gaidhu, M.P., Fediuc, S., Anthony, N.M., So, M., Mirpourian, M., Perry, R.L.,
and Ceddia, R.B. (2009). Prolonged AICAR-induced AMP-kinase activation
promotes energy dissipation in white adipocytes: novel mechanisms inte-
grating HSL and ATGL. J. Lipid Res. 50, 704–715.
Hardie, D.G. (2007). AMP-activated/SNF1 protein kinases: conserved guard-
ians of cellular energy. Nat. Rev. Mol. Cell Biol. 8, 774–785.
Harper, M.E., Green, K., and Brand, M.D. (2008). The efficiency of cellular
energy transduction and its implications for obesity. Annu. Rev. Nutr. 28,
13–33.
Kortum, R.L., and Lewis, R.E. (2004). The molecular scaffold KSR1 regulates
the proliferative and oncogenic potential of cells. Mol. Cell. Biol. 24,
4407–4416.
Kortum, R.L., Costanzo, D.L., Haferbier, J., Schreiner, S.J., Razidlo, G.L., Wu,
M.H., Volle, D.J., Mori, T., Sakaue, H., Chaika, N.V., et al. (2005). Themolecular
scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis. Mol. Cell.
Biol. 25, 7592–7604.
Kortum, R.L., Johnson, H.J., Costanzo, D.L., Volle, D.J., Razidlo, G.L., Fusello,
A.M., Shaw, A.S., and Lewis, R.E. (2006). The molecular scaffold kinase
suppressor of Ras 1 is a modifier of RasV12-induced and replicative senes-
cence. Mol. Cell. Biol. 26, 2202–2214.
Kristensen, P., Judge, M.E., Thim, L., Ribel, U., Christjansen, K.N., Wulff, B.S.,
Clausen, J.T., Jensen, P.B., Madsen, O.D., Vrang, N., et al. (1998). Hypotha-
lamic CART is a new anorectic peptide regulated by leptin. Nature 393, 72–76.
Lazar, M.A. (2005). How obesity causes diabetes: not a tall tale. Science 307,
373–375.
Lowell, B.B., and Spiegelman, B.M. (2000). Towards a molecular under-
standing of adaptive thermogenesis. Nature 404, 652–660.Cell MMarsin, A.S., Bertrand, L., Rider, M.H., Deprez, J., Beauloye, C., Vincent, M.F.,
Van den Berghe, G., Carling, D., and Hue, L. (2000). Phosphorylation and acti-
vation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during
ischaemia. Curr. Biol. 10, 1247–1255.
Michaud, N.R., Therrien, M., Cacace, A., Edsall, L.C., Spiegel, S., Rubin, G.M.,
and Morrison, D.K. (1997). KSR stimulates Raf-1 activity in a kinase-indepen-
dent manner. Proc. Natl. Acad. Sci. USA 94, 12792–12796.
Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S.,
Lehar, J., Puigserver, P., Carlsson, E., Ridderstrale, M., Laurila, E., et al.
(2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation
are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273.
Morrison, D.K., and Davis, R.J. (2003). Regulation of MAP kinase signaling
modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19,
91–118.
Mu, J., Brozinick, J.T., Jr., Valladares, O., Bucan, M., and Birnbaum, M.J.
(2001). A role for AMP-activated protein kinase in contraction- and hypoxia-
regulated glucose transport in skeletal muscle. Mol. Cell 7, 1085–1094.
Muller, J., Cacace, A.M., Lyons, W.E., McGill, C.B., and Morrison, D.K. (2000).
Identification of B-KSR1, a novel brain-specific isoform of KSR1 that functions
in neuronal signaling. Mol. Cell. Biol. 20, 5529–5539.
Muller, J., Ory, S., Copeland, T., Piwnica-Worms, H., and Morrison, D.K.
(2001). C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaf-
fold, KSR1. Mol. Cell 8, 983–993.
Nadler, S.T., Stoehr, J.P., Schueler, K.L., Tanimoto, G., Yandell, B.S., and
Attie, A.D. (2000). The expression of adipogenic genes is decreased in obesity
and diabetes mellitus. Proc. Natl. Acad. Sci. USA 97, 11371–11376.
Nguyen, A., Burack, W.R., Stock, J.L., Kortum, R., Chaika, O.V., Afkarian, M.,
Muller, W.J., Murphy, K.M., Morrison, D.K., Lewis, R.E., et al. (2002). Kinase
suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated
protein kinase activation in vivo. Mol. Cell. Biol. 22, 3035–3045.
Ohmachi, M., Rocheleau, C.E., Church, D., Lambie, E., Schedl, T., and
Sundaram, M.V. (2002). C. elegans ksr-1 and ksr-2 have both unique and
redundant functions and are required for MPK-1 ERK phosphorylation. Curr.
Biol. 12, 427–433.
Ollmann, M.M., Wilson, B.D., Yang, Y.K., Kerns, J.A., Chen, Y., Gantz, I., and
Barsh, G.S. (1997). Antagonism of central melanocortin receptors in vitro and
in vivo by agouti-related protein. Science 278, 135–138.
Ory, S., Zhou, M., Conrads, T.P., Veenstra, T.D., and Morrison, D.K. (2003).
Protein phosphatase 2A positively regulates Ras signaling by dephosphorylat-
ing KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13, 1356–1364.
Pfaffl, M.W. (2001). A new mathematical model for relative quantification in
real-time RT-PCR. Nucleic Acids Res. 29, e45.
Ray, P., Monroe, F.L., Berman, J.D., and Fiedler, J. (1991). Cyanide sensitive
and insensitive bioenergetics in a clonal neuroblastoma x glioma hybrid cell
line. Neurochem. Res. 16, 1121–1124.
Ritt, D.A., Zhou, M., Conrads, T.P., Veenstra, T.D., Copeland, T.D., and Morri-
son, D.K. (2007). CK2 is a component of the KSR1 scaffold complex that
contributes to Raf kinase activation. Curr. Biol. 17, 179–184.
Ruderman, N.B., Saha, A.K., and Kraegen, E.W. (2003). Minireview: malonyl
CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144,
5166–5171.
Sakamoto, K., McCarthy, A., Smith, D., Green, K.A., Grahame Hardie, D.,
Ashworth, A., and Alessi, D.R. (2005). Deficiency of LKB1 in skeletal muscle
prevents AMPK activation and glucose uptake during contraction. EMBO J.
24, 1810–1820.
Sanders, M.J., Grondin, P.O., Hegarty, B.D., Snowden, M.A., and Carling, D.
(2007). Investigating the mechanism for AMP activation of the AMP-activated
protein kinase cascade. Biochem. J. 403, 139–148.
Schwartz, M.W., Seeley, R.J., Campfield, L.A., Burn, P., and Baskin, D.G.
(1996). Identification of targets of leptin action in rat hypothalamus. J. Clin.
Invest. 98, 1101–1106.
Shaw, R.J., Lamia, K.A., Vasquez, D., Koo, S.H., Bardeesy, N., Depinho, R.A.,
Montminy, M., and Cantley, L.C. (2005). The kinase LKB1 mediates glucoseetabolism 10, 366–378, November 4, 2009 ª2009 Elsevier Inc. 377
Cell Metabolism
KSR2 Regulates AMPK and Energy Expenditurehomeostasis in liver and therapeutic effects of metformin. Science 310, 1642–
1646.
Sparti, A., DeLany, J.P., de la Bretonne, J.A., Sander, G.E., and Bray, G.A.
(1997). Relationship between resting metabolic rate and the composition of
the fat-free mass. Metabolism 46, 1225–1230.
Stein, S.C., Woods, A., Jones, N.A., Davison, M.D., and Carling, D. (2000). The
regulation of AMP-activated protein kinase by phosphorylation. Biochem. J.
345, 437–443.
Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L.,
Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., et al.
(2005). Gene set enrichment analysis: a knowledge-based approach for inter-
preting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102,
15545–15550.378 Cell Metabolism 10, 366–378, November 4, 2009 ª2009 ElsevieVillena, J.A., Viollet, B., Andreelli, F., Kahn, A., Vaulont, S., and Sul, H.S. (2004).
Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-
activated protein kinase-alpha2 subunit. Diabetes 53, 2242–2249.
Viollet, B., Andreelli, F., Jorgensen, S.B., Perrin, C., Geloen, A., Flamez, D.,
Mu, J., Lenzner, C., Baud, O., Bennoun, M., et al. (2003). The AMP-activated
protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.
J. Clin. Invest. 111, 91–98.
Wu, M., Neilson, A., Swift, A.L., Moran, R., Tamagnine, J., Parslow, D., Armis-
tead, S., Lemire, K., Orrell, J., Teich, J., et al. (2007). Multiparameter metabolic
analysis reveals a close link between attenuated mitochondrial bioenergetic
function and enhanced glycolysis dependency in human tumor cells. Am.
J. Physiol. Cell Physiol. 292, C125–C136.r Inc.
